PROFOUND MEDICAL CORP's ticker is PRFMF and the CUSIP is 74319B106. A total of 2 filers reported holding PROFOUND MEDICAL CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,548,000 | +35.2% | 232,692 | -90.0% | 1.43% | +22.2% |
| Q3 2019 | $1,885,000 | +70.7% | 2,326,925 | +27.4% | 1.17% | +85.6% |
| Q2 2019 | $1,104,000 | +0.9% | 1,826,925 | 0.0% | 0.63% | +0.6% |
| Q1 2019 | $1,094,000 | +48.6% | 1,826,925 | 0.0% | 0.63% | +21.1% |
| Q4 2018 | $736,000 | -26.8% | 1,826,925 | 0.0% | 0.52% | -14.1% |
| Q3 2018 | $1,005,000 | -24.6% | 1,826,925 | 0.0% | 0.60% | -28.7% |
| Q2 2018 | $1,333,000 | +31.3% | 1,826,925 | +35.4% | 0.84% | +11.8% |
| Q1 2018 | $1,015,000 | +12.3% | 1,348,852 | 0.0% | 0.76% | +13.9% |
| Q4 2017 | $904,000 | -11.5% | 1,348,852 | +0.4% | 0.66% | -14.3% |
| Q3 2017 | $1,021,000 | -7.1% | 1,343,718 | +8.2% | 0.77% | -18.4% |
| Q2 2017 | $1,099,000 | +18.4% | 1,241,530 | +0.3% | 0.95% | +12.2% |
| Q1 2017 | $928,000 | -11.0% | 1,237,935 | -0.9% | 0.84% | -2.0% |
| Q4 2016 | $1,043,000 | +60.7% | 1,248,835 | +91.9% | 0.86% | +68.4% |
| Q3 2016 | $649,000 | -10.7% | 650,790 | 0.0% | 0.51% | -16.7% |
| Q2 2016 | $727,000 | +156.0% | 650,790 | +103.9% | 0.62% | +145.0% |
| Q1 2016 | $284,000 | +517.4% | 319,119 | +296.6% | 0.25% | +638.2% |
| Q4 2015 | $46,000 | – | 80,469 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 3,416,132 | $2,570,000 | 0.92% |
| Gagnon Advisors, LLC | 1,348,852 | $1,015,000 | 0.76% |